Insights from γ-Secretase: Functional Genetics of Hidradenitis Suppurativa.

J Invest Dermatol

Center for Cutaneous Biology and Immunology Research, Department of Dermatology, Henry Ford Health System, Detroit, Michigan, USA; Immunology Research Program, Henry Ford Cancer Institute, Henry Ford Health System, Detroit, Michigan, USA; Wayne State University School of Medicine, Detroit, Michigan, USA; Department of Internal Medicine, Henry Ford Health System, Detroit, Michigan, USA. Electronic address:

Published: August 2021

AI Article Synopsis

  • Hidradenitis suppurativa (HS) is a chronic, inflammatory skin condition with a genetic link and varying prevalence among different racial groups.
  • The exact cause of HS is unclear, but factors like hair follicle blockage and immune response issues may play roles in its development.
  • This review highlights the significance of γ-secretase mutations in a specific group of HS patients and suggests potential directions for further research on the disease.

Article Abstract

Hidradenitis suppurativa (HS) is a chronic, relapsing, and remitting inflammatory disease of the skin with significant heritability and racial disposition. The pathogenesis of HS remains enigmatic, but occlusion of the terminal hair follicle and dysregulation of the local innate immune response may contribute to pathogenesis. Genetic predisposition might also contribute to disease susceptibility and phenotypic heterogeneity because mutations in γ-secretase have been found to underlie a minor but characteristic subset of patients with HS. In this review, we synthesized the current data on γ-secretase in HS, evaluated its importance in the context of disease pathobiology, and discussed avenues of future studies.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316262PMC
http://dx.doi.org/10.1016/j.jid.2021.01.023DOI Listing

Publication Analysis

Top Keywords

hidradenitis suppurativa
8
insights γ-secretase
4
γ-secretase functional
4
functional genetics
4
genetics hidradenitis
4
suppurativa hidradenitis
4
suppurativa chronic
4
chronic relapsing
4
relapsing remitting
4
remitting inflammatory
4

Similar Publications

Introduction: Bruton's tyrosine kinase (BTK) is a cytoplasmic signaling protein expressed across a variety of immune cells, terminally differentiated plasma cells, and natural killer cells. Due to the signal potential and targetable nature of BTK, the use of BTK inhibitors (BTKis) has been proposed for the management of several diseases. Currently, the use of BTKis is under investigations for several dermatological conditions such as pemphigus, systemic lupus erythematosus, hidradenitis suppurativa, atopic dermatitis, and chronic spontaneous urticaria (CSU).

View Article and Find Full Text PDF

A year in review: new treatments and expanded indications in dermatology in 2024.

J Dermatolog Treat

December 2025

Center for Translational Dermatology, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.

Methods: A literature search was conducted on Drugs@FDA: FDA-Approved Drugs for the year 2024 to identify new dermatologic treatments.

Results: In 2024, the FDA approved seven new dermatologic therapies and expanded the indications for seven current therapies. These therapies treat conditions such as atopic dermatitis, hidradenitis suppurativa, prurigo nodularis, molluscum contagiosum, and alopecia areata, among others.

View Article and Find Full Text PDF

Hidradenitis Suppurativa.

Annu Rev Med

January 2025

Division of Dermatology, University College Cork, The National University of Ireland, Cork, Ireland; email:

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease characterized by the formation of nodules, abscesses, and fistulae at intertriginous sites. Pain, pruritus, malodor, and suppuration have a significant impact on quality of life for HS patients. Prevalence figures vary greatly in the literature from 0.

View Article and Find Full Text PDF

Acne vulgaris is a globally prevalent dermatological condition associated with substantial physical and psychological burden. Although acne typically presents during adolescence, it is a chronic condition that also affects many adults. Despite the spectrum of treatments available for acne, limitations in tolerability and safety concerns can present challenges for the use of conventional medications in clinical practice.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!